Filter
567
Text search:
expiry
Featured
67
200
Language
Document type
329
100
45
40
20
14
12
3
1
1
1
1
Countries
74
32
22
20
17
14
14
13
12
11
11
11
10
10
9
8
7
7
6
6
6
5
5
5
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
328
41
34
26
15
14
10
Toolboxes
55
39
22
20
18
15
15
11
11
10
9
8
6
5
4
4
3
3
2
2
2
2
1
The Policy Guidelines and Service Standards for National Sexual and Reproductive Health Programme document outlines the steps on how to offer and deliver services. Improving quality of care is critical to improving clients' health status as well as increasing access to, and utilization of Sexual and
...
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak
...
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
DHS Analytical Studies No. 44 Rockville, Maryland, USA: ICF International.
National Tuberculosis and Leprosy Conrol Programme
Accessed November, 2017
Drug Advisory Board
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
Policy framework.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
